FAK is at the crossroads of integrin and growth factors signalling and, as FAK is overexpressed in many human cancers, FAK is frequently associated with the promotion of oncogenic signals and the inhibition of tumour suppressive pathways. Here, PTK2 is linked to neoplasm.